Breast Radiology Reporting - 1st STU ballot - Local Development build (v0.2.0). See the Directory of published versions

BiRads(r) Assessment Category Codes CodeSystem - XML Representation

(back to description)

Raw xml

Source view

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="BiRadsAssessmentCategoriesCS"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><h2>BiRads(r) Assessment Category Codes CodeSystem</h2><div><p>BiRads(r) Assessment Category code system.</p>
</div><p>This code system http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">Category0<a name="BiRadsAssessmentCategoriesCS-Category0"> </a></td><td>Category 0 (Incomplete)</td><td>Need additional Imaging Evaluation and/or prior Mammograms 
for comparison. 
Recall for additional imaging and/or comparison with 
prior examination(s) 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category2<a name="BiRadsAssessmentCategoriesCS-Category2"> </a></td><td>Category 2 (Benign)</td><td>This is a normal assessment. 
Benign refers to a condition, tumor, or growth that 
is not cancerous. 
This means that it does not spread to other parts 
of the body. 
It does not invade nearby tissue. 
Essentially 0% likelihood of malignancy. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category3<a name="BiRadsAssessmentCategoriesCS-Category3"> </a></td><td>Category 3 (Probably Benign)</td><td>A finding assessed using this category should have 
a &lt;= 2% likelihood of malignancy, 
but greater than the essentially 0% likelihood of 
malignancy of a characteristically 
benign finding. 
A probably benign finding is not expected to change 
over the suggested period of 
imaging surveillance, but the interpreting physician 
prefers to establish stability 
of the finding before recommending management limited 
to routine mammography screening. 
Six month follow-up and/or 
surveillance mammography is recommended. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category4<a name="BiRadsAssessmentCategoriesCS-Category4"> </a></td><td>Category 4 (Suspicious)</td><td>This category is reserved for findings that do not 
have the classic appearance of 
malignancy but are sufficiently suspicious to justify 
a recommendation for biopsy. 
There is a 2% likelihood of malignancy (cancer). 
Almost all recommendations for breast interventional 
procedures will come from assessments 
made using 
this category. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category4A<a name="BiRadsAssessmentCategoriesCS-Category4A"> </a></td><td>Category 4A (Low suspicion)</td><td>Low suspicion for malignancy. 
A malignant finding is not suspected. 
A biopsy or other test will likely still be performed 
in order to determine. 
Tissue diagnosis may be recommended. 
Six month follow-up and/or surveillance mammography 
is recommended. 
Likelihood of malignancy is &gt; 2% to &lt;= 10% likelihood 
of malignancy. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category4B<a name="BiRadsAssessmentCategoriesCS-Category4B"> </a></td><td>Category 4B (Moderate suspicion)</td><td>Category 4B: Moderate suspicion for malignancy. 
It warrants radiologic and pathologic correlation 
after tissue diagnosis. 
Likelihood of malignancy is &gt; 10% to &lt;= 50% likelihood 
of 
malignancy. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category4C<a name="BiRadsAssessmentCategoriesCS-Category4C"> </a></td><td>Category 4C (High suspicion)</td><td>Category 4C: High suspicion for 
malignancy. 
Includes findings that have a high suspicion of malignancy 
but that are not highly 
suggestive of malignancy (category 5). 
Tissue Diagnosis is highly recommended. 
Range for likelihood of malignancy is &gt; 50% to &lt; 
95% likelihood of malignancy. 
It is more likely malignant versus benign. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category5<a name="BiRadsAssessmentCategoriesCS-Category5"> </a></td><td>Category 5 (Highly Suggestive of Malignancy)</td><td>Highly Suggestive of Malignancy. 
Almost certainly predictive of breast cancer with 
a 
value of at least 95%. 
Tissue Diagnosis is highly recommended or required. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr><tr><td style="white-space:nowrap">Category6<a name="BiRadsAssessmentCategoriesCS-Category6"> </a></td><td>Category 6 (Known Biopsy-Proven Malignancy)</td><td>Known Biopsy-Proven Malignancy. 
Surgical excision when clinically 
appropriate. 
This category is only used for findings on a mammogram 
that have already been shown to be cancer by a previous 
biopsy. 
Mammograms may be used in this way to see how well 
the cancer is responding to treatment. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM.</td></tr></table></div>
  </text>
  <url
       value="http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS"/>
  <version value="0.2.0"/>
  <name value="BiRadsAssessmentCategoriesCS"/>
  <title value="BiRads(r) Assessment Category Codes CodeSystem"/>
  <status value="draft"/>
  <date value="2019-11-01T00:00:00+00:00"/>
  <publisher value="Hl7 - Clinical Interoperability Council"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org/Special/committees/cic"/>
    </telecom>
  </contact>
  <description value="BiRads(r) Assessment Category code system."/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="001"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="9"/>
  <concept>
    <code value="Category0"/>
    <display value="Category 0 (Incomplete)"/>
    <definition
                value="Need additional Imaging Evaluation and/or prior Mammograms 
for comparison. 
Recall for additional imaging and/or comparison with 
prior examination(s) 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category2"/>
    <display value="Category 2 (Benign)"/>
    <definition
                value="This is a normal assessment. 
Benign refers to a condition, tumor, or growth that 
is not cancerous. 
This means that it does not spread to other parts 
of the body. 
It does not invade nearby tissue. 
Essentially 0% likelihood of malignancy. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category3"/>
    <display value="Category 3 (Probably Benign)"/>
    <definition
                value="A finding assessed using this category should have 
a &lt;= 2% likelihood of malignancy, 
but greater than the essentially 0% likelihood of 
malignancy of a characteristically 
benign finding. 
A probably benign finding is not expected to change 
over the suggested period of 
imaging surveillance, but the interpreting physician 
prefers to establish stability 
of the finding before recommending management limited 
to routine mammography screening. 
Six month follow-up and/or 
surveillance mammography is recommended. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category4"/>
    <display value="Category 4 (Suspicious)"/>
    <definition
                value="This category is reserved for findings that do not 
have the classic appearance of 
malignancy but are sufficiently suspicious to justify 
a recommendation for biopsy. 
There is a 2% likelihood of malignancy (cancer). 
Almost all recommendations for breast interventional 
procedures will come from assessments 
made using 
this category. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category4A"/>
    <display value="Category 4A (Low suspicion)"/>
    <definition
                value="Low suspicion for malignancy. 
A malignant finding is not suspected. 
A biopsy or other test will likely still be performed 
in order to determine. 
Tissue diagnosis may be recommended. 
Six month follow-up and/or surveillance mammography 
is recommended. 
Likelihood of malignancy is &gt; 2% to &lt;= 10% likelihood 
of malignancy. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category4B"/>
    <display value="Category 4B (Moderate suspicion)"/>
    <definition
                value="Category 4B: Moderate suspicion for malignancy. 
It warrants radiologic and pathologic correlation 
after tissue diagnosis. 
Likelihood of malignancy is &gt; 10% to &lt;= 50% likelihood 
of 
malignancy. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category4C"/>
    <display value="Category 4C (High suspicion)"/>
    <definition
                value="Category 4C: High suspicion for 
malignancy. 
Includes findings that have a high suspicion of malignancy 
but that are not highly 
suggestive of malignancy (category 5). 
Tissue Diagnosis is highly recommended. 
Range for likelihood of malignancy is &gt; 50% to &lt; 
95% likelihood of malignancy. 
It is more likely malignant versus benign. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category5"/>
    <display value="Category 5 (Highly Suggestive of Malignancy)"/>
    <definition
                value="Highly Suggestive of Malignancy. 
Almost certainly predictive of breast cancer with 
a 
value of at least 95%. 
Tissue Diagnosis is highly recommended or required. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
  <concept>
    <code value="Category6"/>
    <display value="Category 6 (Known Biopsy-Proven Malignancy)"/>
    <definition
                value="Known Biopsy-Proven Malignancy. 
Surgical excision when clinically 
appropriate. 
This category is only used for findings on a mammogram 
that have already been shown to be cancer by a previous 
biopsy. 
Mammograms may be used in this way to see how well 
the cancer is responding to treatment. 
[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] 

Valid for the following modalities: MG US MRI NM."/>
  </concept>
</CodeSystem>